- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 15, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The November issue of the Nashville Medical News highlighted 2 meetings conducted by The American Journal of Managed Care® (AJMC®) in an article that ran on page 4-6. The meetings, Patient-Centered Oncology Care in Philadelphia, Pennsylvania, and the Institute for Value-Based Medicine in Nashville, Tennessee, featured speakers Kashyap Patel, MD, CEO of Carolina Blood and Cancer Center, and Stephen Schleicher, MD, MBA, physician and Tennessee Oncology's chair of the Quality and Value Committee at OneOncology, respectively.
A piece in Forbes, “Teva Pharmaceuticals to Resume Production of Scarce Childhood Cancer Drug Vincristine,” featured an article from AJMC®’s sister site The Center for Biosimilars® titled “Senate Bill From Collins, Smith Aims to Tackle Drug Shortages.” The article focused on a bipartisan bill introduced in the Senate that aims to address the growing issue of drug shortages.
An article by mHealth Intelligence, titled “Congress Mulls Federal Support for Specialist Consults Via Telehealth,” cited a study published in the January 2018 issue of AJMC®: “A Cost-Effectiveness Analysis of Cardiology eConsults for Medicaid Patients.” The study showed that a randomized trial of eConsults for cardiology referrals from primary care resulted in significant reductions in total cost of care compared with traditional face-to-face consultations.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
